Patent ID: 7932421
Filing Date: 2011-04-26
Classification: A61P,C07C,C07D

Abstract:
1. A compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, or prodrug thereof, wherein: R each occurrence of R R or R R R or R R wherein any cycloalkyl portion, heterocycloalkyl portion, aryl portion, or heteroaryl portion is optionally substituted with one to four members selected from the group consisting of halogen, cyano, nitro, —CY X is (C each occurrence of Y is independently hydrogen, halogen, or cyano; each occurrence of R′ is independently hydrogen, (C or two R′ groups, when attached to the same nitrogen atom, can combine with the nitrogen atom to which they are attached to form a heterocyclic or heteroaryl group; each occurrence of R″ is independently hydrogen, (C m is an integer from 1 to 5; n is 0 or 1; p is an integer from 0 to 5; and q is an integer from 0 to 5; with the proviso that the compound is not: ethyl or methyl 4-(N-methylbenzamido)cyclohexylacetate; 4-(N-methylbenzamido)cyclohexaneacetic acid; 3,4-dichloro-N-methyl-N-[4-(3-hydroxypropyl)-2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide; 3,4-dichloro-N-methyl-N-[4-(3-methoxypropyl)-2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide; 3,4-dichloro-N-methyl-N-[2-(1-azetidinyl)-3-(3-propionoxypropyl)cyclohexyl]-benzeneacetamide; 4-trifluoromethyl-N-ethyl-N-[3-(3-propyloxypropyl)-2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide; or 3,4-dichloro-N-methyl-N-[4-(3-acetyloxypropyl)-2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide.